Thrombocytopenia means a reduction in the platelet count below the normal lower limit (usually 150 x 109/l ). This can have a variety of causes, including a reduction in platelet production, a reduction in platelet survival, and dilution of platelet numbers resulting from the transfusion of platelet-poor blood.
Pseudothrombocytopenia
This can occur when platelets undergo a phenomenon called 'clumping'. In this situation, the platelets stick together, causing a false low reading when passed through an auto-analyser. The condition is caused by the action of ethylenediaminetetraacetic acid (EDTA) used as an anticoagulant. It occurs in about 0.1% of the population but can also be associated with infections with human immunodeficiency virus, rubella, cytomegalovirus, autoimmune disorders, neoplastic diseases, thrombotic disorders and possibly trauma. It is not indicative of a bleeding diathesis or platelet dysfunction. If an abnormally low platelet count is detected in the absence of a suggestive medical history, examination of a peripheral blood smear on a freshly-taken specimen should be performed.1
On this page
Disorders affecting platelet production
Congenital
- Megakaryocytic hypoplasia - underdevelopment of megakaryocytes which normally develop in bone marrow and fragment to produce platelets - usually of autoimmune or infectious origin
- Thrombocytopaenia/absent radii (TAR) syndrome - radial aplasia or hypoplasia and thrombocytopenia
- Wiskott-Aldrich syndrome - an X-linked recessive disease characterised by thrombocytopenia,
lymphopenia and depressed cellular immunity, eczema, malignant lymphoma - Congenital leukaemia, e.g. Down's syndrome
- Fanconi's anaemia
- Viral infections - e.g. herpes simplex, cytomegalovirus, varicella-zoster, Epstein-Barr, rubella, enterovirus, mumps, hepatitis
- Aplastic anaemia
- Marrow infiltration by a primary neoplasm, e.g. leukaemia or metastatic malignant disease
- Drugs and chemicals - e.g:
- Quinine
- Aspirin
- Antibiotics such as chloramphenicol and sulphonamides
- Heparin
- Gold
- Digoxin
- Phenylbutazone
- Indometacin
- Sulfasalazine
- Alcohol
- Paroxysmal nocturnal haemoglobinuria
- Megaloblastic anaemia
- Myelofibrosis
Decreased platelet survival
- Immune - idiopathic thrombocytopenia purpura, systemic lupus erythematosus, post-transfusion purpura, drug-induced (same drugs as affect platelet production)
- Thrombotic thrombocytopenic purpura
- Haemolytic uraemic syndrome
- Disseminated intravascular coagulation
- Cardiopulmonary bypass
- Hypersplenism
- Strawberry naevi, in Kasabach-Merritt syndrome (cavernous haemangiomata with severe thrombocytopenia, and features of disseminated intravascular coagulation)
Dilutional thrombocytopenia
This is caused by transfusion of large volumes of blood which may be depleted of functioning platelets resulting from prolonged storage.
Presentation, investigations and management
See Thrombocytopathy.
Document references
- Hagerman R; Ethylenediaminetetraacetic Acid (EDTA)-Dependent Pseudothrombocytopenia: A Case Report of an Incidental but Important Finding Priory.com 2009.
- Thiagarajan, P; Platelet Disorders, eMedicine, 2009.
- Thrombocytopenia; Omdict.net 2009
Internet and further reading
- The management of heparin induced thrombocytopenia, British Committee for Standards in Haematology (2006)
- Platelet Disorder Support Association; Low Platelet Disorders 2009.
Acknowledgements
EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.Document ID: 4187
Document Version: 4
Document Reference: bgp26047
Last Updated: 30 Jun 2009